Prospective Observational Long-term Safety Registry of Multiple Sclerosis Patients Who Have Participated in Cladribine Clinical Trials

• Status: Recruiting
• Trial end date: 0000-00-00
• Target enrollment: 1190
• Participant gender: Both

Summary

Prospective Observational Long-term Safety Registry of Multiple Sclerosis Patients who Have Participated in Cladribine Clinical Trials

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: EMD Serono
• Treatments: Cladribine
• Last Updated: 2016-10-14

Criteria

Inclusion Criteria:

• Prior enrollment into selected oral cladribine clinical trials as of randomization to either study drug or placebo, once participation in the clinical trial has ended

• Written informed consent was given

Exclusion Criteria:

• Subjects who cannot be reached by telephone

• Subjects unable to answer the registry questionnaires and who do not have a next of kin or caregiver able to answer the registry questionnaires

• Subjects who - either during the lag interval or subsequently - enter an interventional study